Increased blood vessel density and endothelial cell proliferation in multiple sclerosis cerebral white matter

Neuroscience Letters

Volumn 470, Issue 1, 2010, Pages 65-70

  Holley, Janet E ^a   Newcombe, Jia ^c   Whatmore, Jacqueline L ^a   Gutowski, Nicholas J ^a,b  

^a UNIVERSITY OF EXETER   (United Kingdom)

^b ROYAL DEVON AND EXETER HOSPITAL   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Angiogenesis; Multiple sclerosis; Scarring

Indexed keywords

ENDOGLIN; PROTEIN ANTIBODY;

ANGIOGENESIS; ARTICLE; BASEMENT MEMBRANE; BLOOD BRAIN BARRIER; BLOOD VESSEL; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DEMYELINATING DISEASE; DENSITY; DISEASE COURSE; ENDOTHELIUM CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY DISEASE; MULTIPLE SCLEROSIS; PATHOGENESIS; PRIORITY JOURNAL; SCAR FORMATION; VASCULARIZATION; WHITE MATTER;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; BLOOD VESSELS; BRAIN; CAPILLARIES; CELL PROLIFERATION; ENDOTHELIAL CELLS; HUMANS; MIDDLE AGED; MULTIPLE SCLEROSIS; NEOVASCULARIZATION, PATHOLOGIC; NERVE FIBERS, MYELINATED; RECEPTORS, CELL SURFACE;

EID: 74149084257     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2009.12.059     Document Type: Article

References (26)

1. Aird W.C. Phenotypic heterogeneity of the endothelium: II. Representative vascular beds. Circ. Res. 100 (2007) 174-190
2. Barcia C., Emborg M.E., Hirsch E.C., and Herrero M.T. Blood vessels and Parkinsonism. Front Biosci. 9 (2004) 277-282
3. Barresi V., Cerasoli S., Vitarelli E., and Tuccari G. Density of microvessels positive for CD105 (endoglin) is related to prognosis in meningiomas. Acta Neuropathol. 114 (2007) 147-156
4. Behrem S., Zarkovic K., Eskinja N., and Jonjic N. Endoglin is a better marker than CD31 in evaluation of angiogenesis in glioblastoma. Croat. Med. J. 46 (2005) 417-422
5. Carmeliet P. Angiogenesis in health and disease. Nat. Med. 9 (2003) 653-660
6. Dawson J. The histology of disseminated sclerosis. Trans. R. Soc. Edinb. 108 (1916) 397-399
7. De Groot C.J., Montagne L., Barten A.D., Sminia P., and Van Der Valk P. Expression of transforming growth factor (TGF)-beta1, -beta2, and -beta3 isoforms and TGF-beta type I and type II receptors in multiple sclerosis lesions and human adult astrocyte cultures. J. Neuropathol. Exp. Neurol. 58 (1999) 174-187
8. Dore-Duffy P., Wang X., Mehedi A., Kreipke C.W., and Rafols J.A. Differential expression of capillary VEGF isoforms following traumatic brain injury. Neurol. Res. 29 (2007) 395-403
9. Ge Y., Zohrabian V.M., and Grossman R.I. Seven-Tesla magnetic resonance imaging: new vision of microvascular abnormalities in multiple sclerosis. Arch. Neurol. 65 (2008) 812-816
10. Graumann U., Reynolds R., Steck A.J., and Schaeren-Wiemers N. Molecular changes in normal appearing white matter in multiple sclerosis are characteristic of neuroprotective mechanisms against hypoxic insult. Brain Pathol. 13 (2003) 554-573
11. Holley J.E., Gveric D., Newcombe J., Cuzner M.L., and Gutowski N.J. Astrocyte characterization in the multiple sclerosis glial scar. Neuropathol. Appl. Neurobiol. 29 (2003) 434-444
12. Jain R.K. Tumor angiogenesis and accessibility: role of vascular endothelial growth factor. Semin. Oncol. 29 (2002) 3-9
13. Kirk S., Frank J.A., and Karlik S. Angiogenesis in multiple sclerosis: is it good, bad or an epiphenomenon?. J. Neurol. Sci. 217 (2004) 125-130
14. Kirk S.L., and Karlik S.J. VEGF and vascular changes in chronic neuroinflammation. J. Autoimmun. 21 (2003) 353-363
15. Li H., Newcombe J., Groome N.P., and Cuzner M.L. Characterization and distribution of phagocytic macrophages in multiple sclerosis plaques. Neuropathol. Appl. Neurobiol. 19 (1993) 214-223
16. Minhajat R., Mori D., Yamasaki F., Sugita Y., Satoh T., and Tokunaga O. Organ-specific endoglin (CD105) expression in the angiogenesis of human cancers. Pathol. Int. 56 (2006) 717-723
17. Proescholdt M.A., Jacobson S., Tresser N., Oldfield E.H., and Merrill M.J. Vascular endothelial growth factor is expressed in multiple sclerosis plaques and can induce inflammatory lesions in experimental allergic encephalomyelitis rats. J. Neuropathol. Exp. Neurol. 61 (2002) 914-925
18. Roscoe W.A., Welsh M.E., Carter D.E., and Karlik S.J. VEGF and angiogenesis in acute and chronic MOG((35-55)) peptide induced EAE. J. Neuroimmunol. 209 (2009) 6-15
19. Stevens C.R., Blake D.R., Merry P., Revell P.A., and Levick J.R. A comparative study by morphometry of the microvasculature in normal and rheumatoid synovium. Arthritis Rheum. 34 (1991) 1508-1513
20. Strijbos M.H., Verhoef C., Gratama J.W., and Sleijfer S. On the origin of (CD105+) circulating endothelial cells. Thromb. Haemost. 102 (2009) 347-351
21. Su J.J., Osoegawa M., Matsuoka T., Minohara M., Tanaka M., Ishizu T., Mihara F., Taniwaki T., and Kira J. Upregulation of vascular growth factors in multiple sclerosis: correlation with MRI findings. J. Neurol. Sci. 243 (2006) 21-30
22. Trapp B.D., and Stys P.K. Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis. Lancet Neurol. 8 (2009) 280-291
23. Vagnucci Jr. A.H., and Li W.W. Alzheimer's disease and angiogenesis. Lancet 361 (2003) 605-608
24. Voskuhl R.R., Peterson R.S., Song B., Ao Y., Morales L.B., Tiwari-Woodruff S., and Sofroniew M.V. Reactive astrocytes form scar-like perivascular barriers to leukocytes during adaptive immune inflammation of the CNS. J. Neurosci. 29 (2009) 11511-11522
25. Yao Y., Kubota T., Takeuchi H., and Sato K. Prognostic significance of microvessel density determined by an anti-CD105/endoglin monoclonal antibody in astrocytic tumors: comparison with an anti-CD31 monoclonal antibody. Neuropathology 25 (2005) 201-206
26. Zamboni P., Galeotti R., Menegatti E., Malagoni A.M., Tacconi G., Dall'Ara S., Bartolomei I., and Salvi F. Chronic cerebrospinal venous insufficiency in patients with multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 80 (2009) 392-399